Condition: Allergic Transfusion Reaction · Sponsor: Institute of Hematology & Blood Diseases Hospital, China
This is a prospective, randomized, double-blind controlled trial to evaluate the efficacy of placebo versus chlorpheniramine for the prevention of allergic transfusion reactions.
This description comes directly from the study's public registry record.
Jun Shi, PhD · (86)2223900913 · shijun@ihcams.ac.cn
Jingyu Zhao, MPH · (86)13752253515 · zhaojingyu@ihcams.ac.cn
Always discuss trial participation with your own doctor first.
| Anhui Provincial Hospital | Hefei, Anhui, China | Not Yet Recruiting |
| Zhoukou Central Hospital | Zhoukou, Henan, China | Recruiting |
| The Second Affilated Hospital of Shandong First Medical University | Tai’an, Shandong, China | Recruiting |
| Regenerative Medicine Center | Tianjin, Tianjin Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04688736